Education
About Us
Working with TipRanks
Follow Us
Can-Fite BioPharma Ltd. (IL:CANF)
:CANF
CANF Stock Chart & Stats
1.00
>-0.01(-4.76%)
At close: 4:00 PM EST
1.00
>-0.01(-4.76%)
Day’s Range― - ―
52-Week Range1.00 - 3.50
Previous CloseN/A
Volume13.23M
Average Volume (3M)1.04M
Market Cap
51.22M
Enterprise Value22.92M
Total Cash (Recent Filing)6.46M
Total Debt (Recent Filing)90.00K
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Nov 21, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding5,121,874,500
10 Day Avg. Volume130,742
30 Day Avg. Volume1,039,800
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.09
Price to Sales (P/S)16.84
P/FCF Ratio-1.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Can Fite Bio News
CANF FAQ
What was Can-Fite BioPharma Ltd.’s price range in the past 12 months?
Can-Fite BioPharma Ltd. lowest stock price was 1.00 and its highest was 3.50 in the past 12 months.
What is Can-Fite BioPharma Ltd.’s market cap?
Can-Fite BioPharma Ltd.’s market cap is 51.22M.
When is Can-Fite BioPharma Ltd.’s upcoming earnings report date?
Can-Fite BioPharma Ltd.’s upcoming earnings report date is Nov 21, 2025 which is in 24 days.
How were Can-Fite BioPharma Ltd.’s earnings last quarter?
Can-Fite BioPharma Ltd. released its earnings results on Aug 28, 2025. The company reported 0 earnings per share for the quarter, the consensus estimate of 0 by 0.
Is Can-Fite BioPharma Ltd. overvalued?
According to Wall Street analysts Can-Fite BioPharma Ltd.’s price is currently Overvalued.
Does Can-Fite BioPharma Ltd. pay dividends?
Can-Fite BioPharma Ltd. does not currently pay dividends.
What is Can-Fite BioPharma Ltd.’s EPS estimate?
Can-Fite BioPharma Ltd.’s EPS estimate is 0.
How many shares outstanding does Can-Fite BioPharma Ltd. have?
Can-Fite BioPharma Ltd. has 5,121,874,500 shares outstanding.
What happened to Can-Fite BioPharma Ltd.’s price movement after its last earnings report?
Can-Fite BioPharma Ltd. reported an EPS of 0 in its last earnings report, expectations of 0. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Can-Fite BioPharma Ltd.?
Currently, no hedge funds are holding shares in IL:CANF
Company Description
Can-Fite BioPharma Ltd.
Can Fite BioPharma Ltd. (CANF) is a biopharmaceutical company that operates in the healthcare sector, specifically focusing on the development of small molecule drugs for the treatment of inflammatory, cancer, and liver diseases. The company's pipeline includes proprietary compounds aimed at treating conditions such as psoriasis, rheumatoid arthritis, and hepatocellular carcinoma. Can Fite leverages its expertise in molecular biology and pharmacology to advance its clinical-stage products through various phases of development, seeking to address significant unmet medical needs.